Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 5/20 | 0.37 |
| ▸ | PDE4A | P27815 | 4/20 | 0.37 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | AKT2 | P31751 | 2/20 | 0.33 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | BRD2 | P25440 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3241084 | 0.78 | NPC1 (0.34) | MAPTLMNAHTTALDH1A1KMT2A | |
| SCHEMBL5551256 | 0.73 | MAPT (0.42) | MAPTAKT2BRD4CHEK1BRD2 | |
| SCHEMBL3240740 | 0.72 | METAP2 (0.41) | PDE4BPDE4APDE4CPDE4DESR2 | |
| SCHEMBL20873646 | 0.71 | MAPT (0.43) | PPARGPPARAMAPTAKT2BRD4 | |
| SCHEMBL29473773 | 0.71 | PDE4B (0.48) | PDE4BPDE4APDE4CPDE4DMAPT | |
| SCHEMBL24848661 | 0.70 | MAPT (0.39) | PPARGPPARAMAPTAKT2BRD4 | |
| SCHEMBL5951481 | 0.70 | MAPT (0.44) | PPARGPPARAMAPTAKT2BRD4 | |
| SCHEMBL959273 | 0.70 | ALDH1A1 (0.44) | PPARGPPARAMAPTAKT2BRD4 | |
| SCHEMBL24570925 | 0.70 | BRD4 (0.44) | MAPTAKT2BRD4CHEK1BRD2 | |
| SCHEMBL1470574 | 0.70 | MAPT (0.44) | PPARGPPARAMAPTAKT2BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1225163-B1 | Process for producing isopulegol | TAKASAGO PERFUMERY CO LTD (JP) | 2010-07-28 | — | — | EP | disclosed |
| US-6774269-B2 | CYCLIZATION OF CITRONELLAL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-08-10 | — | — | US | disclosed |
| US-20020133046-A1 | Process for producing isopulegol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-19 | — | — | US | disclosed |
| EP-1225163-A2 | Process for producing isopulegol | Takasago International Corporation (JP) | 2002-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020133046-A1 | Process for producing isopulegol | ACSL3, ACSL1, ACSL6 | PDE4B 3119/4885PDE4A 3064/4885PDE4C 3521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.